180 related articles for article (PubMed ID: 10968371)
1. Regulation of the adhesion versus cytotoxic functions of the Mac-1/CR3/alphaMbeta2-integrin glycoprotein.
Ross GD
Crit Rev Immunol; 2000; 20(3):197-222. PubMed ID: 10968371
[TBL] [Abstract][Full Text] [Related]
2. The beta-glucan-binding lectin site of mouse CR3 (CD11b/CD18) and its function in generating a primed state of the receptor that mediates cytotoxic activation in response to iC3b-opsonized target cells.
Xia Y; Vetvicka V; Yan J; Hanikýrová M; Mayadas T; Ross GD
J Immunol; 1999 Feb; 162(4):2281-90. PubMed ID: 9973505
[TBL] [Abstract][Full Text] [Related]
3. Generation of recombinant fragments of CD11b expressing the functional beta-glucan-binding lectin site of CR3 (CD11b/CD18).
Xia Y; Ross GD
J Immunol; 1999 Jun; 162(12):7285-93. PubMed ID: 10358177
[TBL] [Abstract][Full Text] [Related]
4. Beta-glucan, a "specific" biologic response modifier that uses antibodies to target tumors for cytotoxic recognition by leukocyte complement receptor type 3 (CD11b/CD18).
Yan J; Vetvicka V; Xia Y; Coxon A; Carroll MC; Mayadas TN; Ross GD
J Immunol; 1999 Sep; 163(6):3045-52. PubMed ID: 10477568
[TBL] [Abstract][Full Text] [Related]
5. Function of the lectin domain of Mac-1/complement receptor type 3 (CD11b/CD18) in regulating neutrophil adhesion.
Xia Y; Borland G; Huang J; Mizukami IF; Petty HR; Todd RF; Ross GD
J Immunol; 2002 Dec; 169(11):6417-26. PubMed ID: 12444150
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the sugar specificity and molecular location of the beta-glucan-binding lectin site of complement receptor type 3 (CD11b/CD18).
Thornton BP; Vĕtvicka V; Pitman M; Goldman RC; Ross GD
J Immunol; 1996 Feb; 156(3):1235-46. PubMed ID: 8558003
[TBL] [Abstract][Full Text] [Related]
7. Soluble beta-glucan polysaccharide binding to the lectin site of neutrophil or natural killer cell complement receptor type 3 (CD11b/CD18) generates a primed state of the receptor capable of mediating cytotoxicity of iC3b-opsonized target cells.
Vetvicka V; Thornton BP; Ross GD
J Clin Invest; 1996 Jul; 98(1):50-61. PubMed ID: 8690804
[TBL] [Abstract][Full Text] [Related]
8. Role of the lectin domain of Mac-1/CR3 (CD11b/CD18) in regulating intercellular adhesion.
Ross GD
Immunol Res; 2002; 25(3):219-27. PubMed ID: 12018461
[TBL] [Abstract][Full Text] [Related]
9. Targeting of natural killer cells to mammary carcinoma via naturally occurring tumor cell-bound iC3b and beta-glucan-primed CR3 (CD11b/CD18).
Vetvicka V; Thornton BP; Wieman TJ; Ross GD
J Immunol; 1997 Jul; 159(2):599-605. PubMed ID: 9218574
[TBL] [Abstract][Full Text] [Related]
10. Surface receptors of neutrophils towards B. burgdorferi.
Cinco M; Murgia R; Perticarari S; Presani G
Wien Klin Wochenschr; 1998 Dec; 110(24):866-9. PubMed ID: 10048167
[TBL] [Abstract][Full Text] [Related]
11. Regulation of CR3 (CD11b/CD18)-dependent natural killer (NK) cell cytotoxicity by tumour target cell MHC class I molecules.
Vĕtvicka V; Hanikýrová M; Vĕtvicková J; Ross GD
Clin Exp Immunol; 1999 Feb; 115(2):229-35. PubMed ID: 9933447
[TBL] [Abstract][Full Text] [Related]
12. Leukocyte complement receptors and adhesion proteins in the inflammatory response: insights from an experiment of nature.
Springer TA; Anderson DC
Biochem Soc Symp; 1986; 51():47-57. PubMed ID: 2949749
[TBL] [Abstract][Full Text] [Related]
13. Beta-glucan functions as an adjuvant for monoclonal antibody immunotherapy by recruiting tumoricidal granulocytes as killer cells.
Hong F; Hansen RD; Yan J; Allendorf DJ; Baran JT; Ostroff GR; Ross GD
Cancer Res; 2003 Dec; 63(24):9023-31. PubMed ID: 14695221
[TBL] [Abstract][Full Text] [Related]
14. AlphaMbeta2 (CD11b/CD18, Mac-1) integrin activation by a unique monoclonal antibody to alphaM I domain that is divalent cation-sensitive.
Orchekowski RP; Plescia J; Altieri DC; Bajt ML
J Leukoc Biol; 2000 Nov; 68(5):641-9. PubMed ID: 11073102
[TBL] [Abstract][Full Text] [Related]
15. Interaction with Borrelia burgdorferi causes increased expression of the CR3 integrin and increased binding affinity to fibronectin via CR3.
Cinco M; Panfili E; Presani G; Perticarari S
J Mol Microbiol Biotechnol; 2000 Oct; 2(4):575-9. PubMed ID: 11075934
[TBL] [Abstract][Full Text] [Related]
16. Non-PKC DAG/phorbol-ester receptor(s) inhibit complement receptor-3 and nPKC inhibit scavenger receptor-AI/II-mediated myelin phagocytosis but cPKC, PI3k, and PLCgamma activate myelin phagocytosis by both.
Cohen G; Makranz C; Spira M; Kodama T; Reichert F; Rotshenker S
Glia; 2006 Apr; 53(5):538-50. PubMed ID: 16374778
[TBL] [Abstract][Full Text] [Related]
17. A dysfunctional Mo1 glycoprotein is present on a subline of the KG1 acute myelogenous leukemia cell line.
Dana N; Todd RF; Colten HR; Arnaout MA
J Immunol; 1987 May; 138(10):3549-54. PubMed ID: 2437197
[TBL] [Abstract][Full Text] [Related]
18. The function of human NK cells is enhanced by beta-glucan, a ligand of CR3 (CD11b/CD18).
Di Renzo L; Yefenof E; Klein E
Eur J Immunol; 1991 Jul; 21(7):1755-8. PubMed ID: 2060581
[TBL] [Abstract][Full Text] [Related]
19. CR3 (CD11b, CD18): a phagocyte and NK cell membrane receptor with multiple ligand specificities and functions.
Ross GD; Vĕtvicka V
Clin Exp Immunol; 1993 May; 92(2):181-4. PubMed ID: 8485905
[TBL] [Abstract][Full Text] [Related]
20. Modulation (inhibition and augmentation) of complement receptor-3-mediated myelin phagocytosis.
Reichert F; Slobodov U; Makranz C; Rotshenker S
Neurobiol Dis; 2001 Jun; 8(3):504-12. PubMed ID: 11442357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
